Technology & ScienceNVIDIA's BioNeMo Becomes Global Drug Discovery's Default AI Infrastructure as Big Pharma Cedes Biology to SpecialistsSalvado•May 21, 2026
Health & BiotechNVIDIA's BioNeMo Becomes Global Pharma Infrastructure as Novo Nordisk, Eli Lilly Rebuild R&D Around AISalvado•May 18, 2026
Health & ScienceNovo Nordisk Shares Surge 24.9% as Global Pharma Abandons Wet Labs for AISalvado•May 13, 2026
Healthcare & PharmaceuticalsPfizer Joins the Global Obesity Race: GLP-1 Market Entry Planned by 2028 Following Metsera AcquisitionViaNews Editorial Team•Feb 18, 2026
